Zee W. Wong

Clayton, VIC, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Oncological Care Needs of People With Mental Illness: A Single Institution Experience in Australia.

Oncological Care Needs of People With Mental Illness: A Single Institution Experience in Australia.

Journal: Asia-Pacific journal of clinical oncology

Published: October 31, 2025

Effects of current smoking on treatment outcomes in metastatic and locally advanced pancreatic carcinoma: a retrospective cohort study using the international PURPLE pancreas cancer registry.

Effects of current smoking on treatment outcomes in metastatic and locally advanced pancreatic carcinoma: a retrospective cohort study using the international PURPLE pancreas cancer registry.

Journal: Journal of gastrointestinal oncology

Published: March 09, 2025

Solving unknown primary cancer with earlier diagnosis - the SUPER-ED trial: study protocol for a stepped-wedge cluster randomised controlled trial to support earlier diagnosis for people presenting with malignancy of undefined primary origin.

Solving unknown primary cancer with earlier diagnosis - the SUPER-ED trial: study protocol for a stepped-wedge cluster randomised controlled trial to support earlier diagnosis for people presenting with malignancy of undefined primary origin.

Journal: BMC cancer

Published: February 14, 2024

ASCEND: a randomised, double-blinded, placebo-controlled, phase II study of gemcitabine and nab-paclitaxel with LSTA1 in untreated metastatic pancreatic adenocarcinoma. An Australasian Gastro-Intestinal Trials Group (AGITG) trial.

ASCEND: a randomised, double-blinded, placebo-controlled, phase II study of gemcitabine and nab-paclitaxel with LSTA1 in untreated metastatic pancreatic adenocarcinoma. An Australasian Gastro-Intestinal Trials Group (AGITG) trial.

Journal: ESMO gastrointestinal oncology

Published: July 09, 2023

Telehealth in cancer care during the COVID-19 pandemic.

Telehealth in cancer care during the COVID-19 pandemic.

Journal: Journal of telemedicine and telecare

Published: December 09, 2022

A capability framework to inform the fundamental requirements for clinical trial unit development, growth and long term success in outer metropolitan and rural areas.

A capability framework to inform the fundamental requirements for clinical trial unit development, growth and long term success in outer metropolitan and rural areas.

Journal: Contemporary clinical trials communications

Published: August 16, 2022

Patient preferences using telehealth during the COVID-19 pandemic in four Victorian tertiary hospital services.

Patient preferences using telehealth during the COVID-19 pandemic in four Victorian tertiary hospital services.

Journal: Internal medicine journal

Published: October 25, 2021

COVID-19 recovery: implications for cancer care clinicians.

COVID-19 recovery: implications for cancer care clinicians.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Published: July 26, 2021

Telehealth in cancer care during the COVID-19 pandemic.

Telehealth in cancer care during the COVID-19 pandemic.

Journal: The Medical journal of Australia

Published: August 18, 2020

Complete response of metastatic pleomorphic dermal sarcoma to anti-PD-1 therapy.

Complete response of metastatic pleomorphic dermal sarcoma to anti-PD-1 therapy.

Journal: The British journal of dermatology

Published: July 14, 2020

Towards new models of cancer care in Australia: lessons from Victoria's response to the COVID-19 pandemic.

Towards new models of cancer care in Australia: lessons from Victoria's response to the COVID-19 pandemic.

Journal: Internal medicine journal

Published: June 09, 2020

Attitudes of physicians toward assessing risk and using granulocyte colony-stimulating factor as primary prophylaxis in patients receiving chemotherapy associated with an intermediate risk of febrile neutropenia.

Attitudes of physicians toward assessing risk and using granulocyte colony-stimulating factor as primary prophylaxis in patients receiving chemotherapy associated with an intermediate risk of febrile neutropenia.

Journal: Medical oncology (Northwood, London, England)

Published: July 31, 2015

Showing 1-12 of 12

Last Updated: 09/26/2026